According to a report published by Grand View Research, Inc.; the global exosomes market is anticipated to reach around USD 2.28 billion by 2030. Increasing number of research grants and projects by numerous research organizations is anticipated to propel the global market. Rising funding to conduct research activities is expected to further boost the market over the forecast period (2014 to 2030). In addition, involvement of exosomes in various functions and availability of a variety of pathways are projected to support research activities to generate revenue.
Nanovesicles play an important role in intercellular communication. This is expected to increase Research and Development (R&D) activities, thereby driving revenue growth in the coming years. Application of vesicles as carriers of many functional contents including proteins, lipids, and circulating nucleic acids is also likely to support market growth. In addition, crucial applications in diagnosis and treatment of various diseases is likely to increase adoption in research area. These vesicles also play crucial role in tumor pathogenesis and immunosurveillance.
Rising research activities to find the role of exosomes in Hepatocellular Carcinoma (HCC) is expected to boost the market over the forecast period. Moreover, technological advancements and new platforms can further support market expansion over the projected period. New platforms will allow to find low abundant membrane proteins and this finding can be carried out in background of complex plasma proteins. This factor is anticipated to bode well for the overall market growth in near future.
Full Research Report On Exosomes Market Analysis: https://www.grandviewresearch.com/industry-analysis/exosomes-market
The worldwide exosomes market can be segmented on the basis of workflow, biomolecule type, application, and region. As per workflow, the market can be classified into downstream analysis and isolation methods. Downstream analysis is anticipated to dominate the market by 2030 due to increasing requirement for advanced technologies and instrumentation for downstream processing.
Based on biomolecule type, the market for exosomes can be split into non-coding RNAs, mRNA, proteins /peptides, DNA fragments, and Lipids. Non-coding RNA is expected to capture a significant market share in near future due to rising applications in research. In addition, implementation of specific protocols for research in non-coding RNA and prediction of its secondary structure is expected to boost segment growth over the forecast period. DNA fragment is expected to grow at a substantial pace over the forecast period on account of its application of pre-clinical animal models.
On the basis of application, the exosomes market can be divided into neurodegenerative diseases, cancer, cardiovascular diseases, infectious diseases, and others. Cancer dominated the application segment in terms of market share 2016. Growing penetration of organizations in oncology-based research on biomarker identification is anticipated to drive growth in years to come. Exosomes are extensively used in non-invasive biomarkers. Neurodegenerative disorder is expected to showcase significant growth in the forthcoming years due to increased research regarding the use of these vesicles as a therapeutic tools for brain ailments and as disease biomarker.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Geographically, the market can be divided into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa (MEA).
In 2016, North America held the largest revenue share. Existence of several government and private organizations involved in development of new technologies and a steady rise in funding for R&D activities in the U.S. are the major regional drivers. In 2017, researchers at the Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center acknowledged two grants from the Sohn Conference Foundation to conduct R&D in characterization and isolation of tumor-derived exosomes to examine occurrence of cancer in children.
Asia Pacific is expected to be the fastest growing region over the forecast period due to enormous potential recognized in developing countries like India and China. Increasing government backing and competitive tactics implemented by the organizations to conduct R&D may bode well for the regional market growth over the forecast period.
Key companies operating in the exosomes market include Thermo Fisher Scientific, Inc.; Illumina, Inc.; Takara Bio Company; Miltenyi Biotec; and Qiagen. Market participants are focusing on setting up production facilities to develop particular exosomes cell lines to gain larger market share. Companies are competing with each other on the basis of patent filling and innovation in terms of product development. The market is expected to witness participation of numerous new entrants in near future.
Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/exosomes-market
